The table below shows Relay Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$15.36M
$10.01M
$25.55M
$1.38M
$3.03M
$82.65M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
$99.86M
SG&A
$56.71M
RLAY annual revenue (10-K history)
Relay Therapeutics, Inc. reported annual revenue of $15.36M for fiscal year 2025. That is up 53.4% from $10.01M in fiscal 2024. Over the 6 fiscal years shown, annual revenue declined from $82.65M (FY 2020) to $15.36M. Figures come from the company's audited annual reports as filed with the SEC.
